This page is part of the FHIR Specification (v5.0.0-ballot: FHIR R5 Ballot Preview). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B
Clinical Decision Support Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Not linked to any defined compartments |
Raw JSON (canonical form + also see JSON Format Specification)
Alteplase for Stroke
{ "resourceType": "EvidenceVariable", "id": "example-alteplase-for-stroke", "text": { "status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n <p>\n "Alteplase for Stroke" is an exposure concept with a detailed dosing instruction that may be used in expressing what an Evidence is about.\n </p>\n\t</div>" }, "title": "Alteplase for Stroke", "status": "draft", "actual": true, "characteristic": [ { "description": "IV alteplase 0.9 mg/kg (maximum 90 mg) as 10% of dose over 1 minute and 90% over 1 hour", "definitionCanonical": "http://example.org/fhir/ActivityDefinition/example-alteplase-dosing" } ] }
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.